We Feel Happy to Talk +918657516534
Get In Touch
We Feel Happy to Talk +918657516534
Composition : EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE
by MYLAN PHARMACEUTICALS PVT LTD
Composition : EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE
by SHIVNAAM TRADELINK LLP
Tafnat EM Tablet is an antiretroviral medication used in the treatment of HIV infection. It contains a combination of three active ingredients Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate.
EMTRICITABINE,TENOFOVIR DISOPROXIL FUMARATE
NATCO PHARMA LTD
HIV Infection
30 TABLET(s) IN A BOTTLE
TABLET
Generic Name/Composition : EMTRICITABINE,TENOFOVIR DISOPROXIL FUMARATE
Manufacturer : NATCO PHARMA LTD
Indication : HIV Infection
Packaging : 30 TABLET(s) IN A BOTTLE
Dosage Form : TABLET
Tafnat EM Tablet is an antiretroviral medication used in the treatment of HIV infection. It contains a combination of three active ingredients Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate. Efavirenz belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs), while Lamivudine and Tenofovir Disoproxil Fumarate are nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs). Together, these medicines work by blocking the replication of the HIV virus, helping to lower the viral load in the body, strengthen the immune system, and slow the progression of the disease when used as part of combination antiretroviral therapy. Tafnat EM Tablet should not be used by individuals who are allergic to Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate, or any of the tablet’s ingredients. Patients with a history of pancreatitis, heart rhythm disorders (QT prolongation), seizures, mental health conditions, bone disease, fractures, or liver and kidney problems should inform their doctor before starting treatment. During therapy, healthcare providers may regularly monitor blood counts, bone mineral density, and liver and kidney function to reduce the risk of complications. Women who are pregnant or planning to become pregnant should consult their doctor before taking this medication, and breastfeeding is generally not recommended because HIV can be transmitted from mother to baby through breast milk.
Tafnat EM Tablet is used in the treatment and management of HIV infection. It helps reduce the amount of HIV in the body by preventing the virus from multiplying, which supports the immune system and slows the progression of the disease. When taken regularly as part of combination antiretroviral therapy (ART), it helps lower the viral load, reduce the risk of opportunistic infections, and improve overall quality of life for people living with HIV.
Like other antiretroviral medicines, Tafnat EM Tablet may cause some side effects in certain individuals. These can be mild or serious depending on the patient’s health condition and response to the medication.
Note : If any severe or persistent symptoms occur, seek medical attention immediately.
1. Do not use Tafnat EM Tablet if you are allergic to Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate, or any of its ingredients.
2. Use with caution in patients with liver disease, kidney problems, or chronic hepatitis B or C.
3. Patients with a history of pancreatitis, seizures, heart rhythm problems (QT prolongation), or mental health disorders should inform their doctor before starting treatment.
4. This medicine may affect bone health and kidney function, so regular medical monitoring may be required.
5. Inform your doctor about all medicines, supplements, or herbal products you are taking to avoid possible drug interactions.
6. Pregnancy and breastfeeding: Consult your doctor if you are pregnant or planning pregnancy; breastfeeding is generally not recommended for women with HIV.
7. Store the tablets at room temperature (below 30°C).
8. Keep the medicine in a cool, dry place away from direct sunlight and moisture.
Tafnat EM Tablet is used in the treatment of HIV infection. It helps control the virus and supports the immune system when used as part of antiretroviral therapy (ART).
It contains Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate, which work together to prevent HIV from multiplying in the body, helping to reduce the viral load.
No, Tafnat EM Tablet does not cure HIV, but it helps control the virus and slow the progression of the disease.
People who are allergic to Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate, or any ingredients in the tablet should avoid taking it.
Take the missed dose as soon as you remember. If it is close to the next dose, skip the missed dose and continue your regular schedule. Do not take a double dose.
Yes, doctors may monitor liver function, kidney function, blood counts, and bone health during treatment.
Yes, it may interact with certain prescription drugs, over-the-counter medicines, and herbal supplements, so inform your doctor about all medications you are taking.
Pregnant women or those planning pregnancy should consult their doctor before using this medicine.
Breastfeeding is not recommended for women with HIV, as the virus may be transmitted to the baby through breast milk.
HIV treatment is usually long-term or lifelong, and the medicine should be taken regularly as prescribed by a healthcare provider.
Generic Name/Composition : EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE
Manufacturer : NATCO PHARMA LTD
Indication : HIV Infection
Packaging : 30 TABLET(s) IN A BOTTLE
Dosage Form : TABLET
Tafnat EM Tablet is an antiretroviral medication used in the treatment of HIV infection. It contains a combination of three active ingredients Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate. Efavirenz belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs), while Lamivudine and Tenofovir Disoproxil Fumarate are nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs). Together, these medicines work by blocking the replication of the HIV virus, helping to lower the viral load in the body, strengthen the immune system, and slow the progression of the disease when used as part of combination antiretroviral therapy. Tafnat EM Tablet should not be used by individuals who are allergic to Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate, or any of the tablet’s ingredients. Patients with a history of pancreatitis, heart rhythm disorders (QT prolongation), seizures, mental health conditions, bone disease, fractures, or liver and kidney problems should inform their doctor before starting treatment. During therapy, healthcare providers may regularly monitor blood counts, bone mineral density, and liver and kidney function to reduce the risk of complications. Women who are pregnant or planning to become pregnant should consult their doctor before taking this medication, and breastfeeding is generally not recommended because HIV can be transmitted from mother to baby through breast milk.
Tafnat EM Tablet is used in the treatment and management of HIV infection. It helps reduce the amount of HIV in the body by preventing the virus from multiplying, which supports the immune system and slows the progression of the disease. When taken regularly as part of combination antiretroviral therapy (ART), it helps lower the viral load, reduce the risk of opportunistic infections, and improve overall quality of life for people living with HIV.
Like other antiretroviral medicines, Tafnat EM Tablet may cause some side effects in certain individuals. These can be mild or serious depending on the patient’s health condition and response to the medication.
Note : If any severe or persistent symptoms occur, seek medical attention immediately.
1. Do not use Tafnat EM Tablet if you are allergic to Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate, or any of its ingredients.
2. Use with caution in patients with liver disease, kidney problems, or chronic hepatitis B or C.
3. Patients with a history of pancreatitis, seizures, heart rhythm problems (QT prolongation), or mental health disorders should inform their doctor before starting treatment.
4. This medicine may affect bone health and kidney function, so regular medical monitoring may be required.
5. Inform your doctor about all medicines, supplements, or herbal products you are taking to avoid possible drug interactions.
6. Pregnancy and breastfeeding: Consult your doctor if you are pregnant or planning pregnancy; breastfeeding is generally not recommended for women with HIV.
7. Store the tablets at room temperature (below 30°C).
8. Keep the medicine in a cool, dry place away from direct sunlight and moisture.
Tafnat EM Tablet is used in the treatment of HIV infection. It helps control the virus and supports the immune system when used as part of antiretroviral therapy (ART).
It contains Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate, which work together to prevent HIV from multiplying in the body, helping to reduce the viral load.
No, Tafnat EM Tablet does not cure HIV, but it helps control the virus and slow the progression of the disease.
People who are allergic to Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate, or any ingredients in the tablet should avoid taking it.
Take the missed dose as soon as you remember. If it is close to the next dose, skip the missed dose and continue your regular schedule. Do not take a double dose.
Yes, doctors may monitor liver function, kidney function, blood counts, and bone health during treatment.
Yes, it may interact with certain prescription drugs, over-the-counter medicines, and herbal supplements, so inform your doctor about all medications you are taking.
Pregnant women or those planning pregnancy should consult their doctor before using this medicine.
Breastfeeding is not recommended for women with HIV, as the virus may be transmitted to the baby through breast milk.
HIV treatment is usually long-term or lifelong, and the medicine should be taken regularly as prescribed by a healthcare provider.
Sourced from Manufacturers
Air Express Delivery
Trusted Medicines
Get Up to 85% Off
